BPC-157 vs TB-500 for Tissue Repair: A Research Comparison
An evidence-based comparison of the two most-studied recovery peptides. Covers their distinct mechanisms (angiogenesis vs actin regulation), where each has the strongest research, and the rationale researchers cite for combining them.
By Tier One Research Team —
References
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review — PHARMACEUTICALS (2025)
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing — FRONT PHARMACOL (2021)
- Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications — EXPERT OPIN BIOL THER (2012)
- A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers — ANN N Y ACAD SCI (2010)
- BPC-157 — CID 9941957 — PUBCHEM